ISSN Annaházi, Anita; Polyák, Ilona; Nagy, Ferenc; Wittmann, Tibor; Molnár, Tamás: "Ulcerative crepitus" - A case with subcutaneous emphysema and pneumomediastinum without colonic perforation or toxic megacolon in ulcerative colitis successfully treated conservatively. Neural plasticity, Terjedelem: 8 p. ISSN Borda, Bernadett: Marginális és ideális donorokból származó vesével transzplantált betegek utánkövetése.
Search Menu Abstract Background. Remikiren is an orally active renin inhibitor with established antihypertensive efficacy.
As a single dose it induces renal vasodilatation, suggesting specific renal actions. Data on the renal effects of continued treatment by renin inhibition are not available, either in subjects with normal, or in subjects with impaired renal function. The effect of 8 days of treatment with remikiren mg o. Remikiren induced a significant peak fall in mean arterial pressure of Continued treatment with remikiren induced a sustained fall in blood pressure, renal vasodilatation, negative sodium balance, and a reduction in glomerular protein leakage.
These data are consistent with a renoprotective potential of renin inhibition. When administered systemically, renin inhibitors reduce blood pressure in healthy volunteers and hypertensive patients more or less similarly to ACEi [ 4—7 ].
The renal haemodynamic actions of renin inhibitors so far have been consistent with a renoprotective potential. Remarkably, in accordance with earlier animal data [ 1516 ], the renal vasodilator response to renin inhibition was reported to exceed the response to ACE inhibition [ 17 ]. As the clinical application of renin inhibitors has been hampered by their low bioavailability, the experience with these compounds during maintenance treatment in man is very limited.
No data are available thus far on the renal effects of continued treatment with remikiren, or on the renal effects of renin inhibition in patients with renal function impairment and proteinuria.
In the present study, therefore, we report on the renal and systemic effects of continued treatment for 8 days the renin inhibitor remikiren in hypertensive patients with normal renal function, as well as in patients with impaired renal function and proteinuria. Subjects and methods Patients and protocol Fourteen caucasian patients with mild to moderate hypertension diastolic blood pressure between 90 and mmHg were included.
No other clinical relevant target organ damage was allowed. All subjects gave their informed consent and the study was approved by the Ethical Committee of the Hospital.
- Recommended Articles Összefoglaló.
- Emylcamate—Its Use in Orthopedic Practice | JAMA Surgery | JAMA Network
- Rcog guidelines gestational diabetes 2021
- Вновь заболела грудь: как люди объяснили ты встретилась с даже тогда, когда несколько дней он им возводить столь - нечто вроде.
Median age of the patients was 53 years range 32— The median body mass index at baseline was Histological diagnoses were glomerulosclerosis 3 ; membranous glomerulopathy 2journal of diabetes investigation endnote IgA nephropathy 1. Systolic blood pressure at entry was ±2 mmHg range — and diastolic blood pressure was ±2 mmHg range 90— ; these values were similar for the essential hypertensives and the renal patients.
In the essential hypertensives median albuminuria at entry was In the renal patients nephrotic range proteinuria was present, with a median of All antihypertensives had been withdrawn at least 3 weeks prior to the study, with the exception of one proteinuric patient in whom diuretic treatment was necessary.
Emylcamate—Its Use in Orthopedic Practice
The dose of the diuretic was kept constant throughout the protocol. This patient was excluded from the analysis of electrolyte balance. During hospitalization they received a diet containing 50 mmol sodium, mmol potassium, 60 g protein, and journal of diabetes investigation endnote fluids daily. During this baseline period, stabilization of blood pressure, proteinuria, and electrolyte excretion was established.
Subsequently, remikiren treatment mg orally o. Blood pressure was measured daily between 11 and 12 a.
Renal haemodynamic measurements were performed pretreatment and on the fifth day of remikiren treatment. On the first and the last treatment day timed blood samples were drawn for measurement of plasma renin activity PRAimmunoreactive renin irRand angII.
Tételek ahol a kar "Általános Orvostudományi Kar" és a mű dátuma 2012
For each hour the mean value was calculated. Urinary protein was measured by the pyrogallol red—molybdate method. This method has a coefficient of variation of
- Központi Könyvtár - Semmelweis Publikációk
- Diabetes ízületi fájdalom viszketés által testkezelés
- Népi kezelés a cukorbetegségtől